Psychosis News and Research

RSS

Psychosis means abnormal condition of the mind, and is a generic psychiatric term for a mental state often described as involving a "loss of contact with reality". People suffering from psychosis are said to be ''psychotic.''

FDA approves first digital pill with sensor - Abilify MyCite

The United States Food and Drugs Administration (FDA), for the first time has approved a digital pill system. The novel pill comes with an in-built sensor that transmits information to a remote location after a person has taken it. Experts believe this is a huge step towards digital medicine and opens new avenues for therapy and diagnostics.

14 Nov 2017

FDA approves first drug with digital ingestion tracking system

The U.S. Food and Drug Administration today approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor embedded in the pill that records that the medication was taken.

14 Nov 2017

ACADIA Pharmaceuticals announces results from Phase II study of antipsychotic in Alzheimer's disease psychosis

ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system (CNS) disorders, today announced the presentation of data from the Phase II -019 Study of pimavanserin in Alzheimer's disease psychosis at the 10th Clinical Trials on Alzheimer's Disease meeting in Boston.

3 Nov 2017

Healthy people with psychotic-like experiences have altered brain dynamics, study finds

Healthy people experiencing subtle symptoms observed in psychotic disorders, such as hallucinations and delusions, have altered brain dynamics, according to a new study published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.

1 Nov 2017

Cochrane review provides clarity about safety of mefloquine for preventing malaria in travelers

Researchers from LSTM Cochrane Infectious Diseases Group publish two systematic reviews this week about the safety of mefloquine (Lariam) for preventing malaria in travelers.

30 Oct 2017

Sunovion announces results from Phase 3 clinical study of new drug in children, adolescents with bipolar depression

Sunovion Pharmaceuticals Inc. today announced post-hoc analysis results of a positive Phase 3 placebo-controlled clinical study, as well as interim data from a long-term open-label extension study evaluating Latuda (lurasidone HCI) in children and adolescents (10 to 17 years of age) with major depressive episodes associated with bipolar I disorder (bipolar depression).

28 Oct 2017

Study explores mechanisms of psychotherapy in individuals at very high risk of psychosis

In the current issue of Psychotherapy and Psychosomatics a study explores the mechanisms of psychotherapy in subjects at very high risk of psychosis. Cognitive-behavioral therapy (CBT) is the first-choice treatment in clients with ultra-high risk (UHR) for psychosis.

24 Oct 2017

USC study reveals how schizophrenia has biological effect on the entire brain

Some 40 years since CT scans first revealed abnormalities in the brains of schizophrenia patients, international scientists say the disorder is a systemic disruption to the brain's entire communication system.

17 Oct 2017

Expert report provides new insight into nature of mental illness

A week after the government announced its review of mental health legislation, an expert report published by the British Psychological Society's Division of Clinical Psychology on Friday 13 October challenges received wisdom about the nature of mental illness.

11 Oct 2017

Web-based therapies increase likelihood of people with severe mental illness finding work

Patients living with severe mental illness are being helped to return to work courtesy of new research from Sydney's Westmead Institute for Medical Research.

11 Oct 2017

Study finds brain chemical elevations in young people experiencing first episode of psychosis

A new study of young people experiencing a first episode of psychosis reports elevations in the brain chemicals glutamate and glycine. Published in Biological Psychiatry, the study led by Dr. Dost öngür of Harvard Medical School provides the first-ever measurement of glycine levels in patients with psychotic disorders.

11 Oct 2017

Researchers find gaps in knowledge about causes of symptoms in dementia patients

Behavioral and psychological symptoms are difficult for dementia patients and their caregivers, but despite research efforts, there are still gaps in knowledge about what causes or precipitates these symptoms, according to researchers.

10 Oct 2017

Study reveals marijuana's potential effects in individuals at high risk for psychotic disorder

Marijuana may bring on temporary paranoia and other psychosis-related effects in individuals at high risk of developing a psychotic disorder, finds a preliminary study from researchers at Columbia University Medical Center.

14 Sep 2017

New approaches to prevent or treat antipsychotic-induced supersensitivity psychosis

In the current issue of Psychotherapy and Psychosomatic, professor Guy Chouinard, one of the most important psychopharmacologists, provides a synthesis of the data that are concerned with neglected side effects of commonly used psychotropic drugs.

8 Sep 2017

Psychotic experiences double risk of suicidal thoughts and behaviors, study finds

Otherwise healthy people who experience hallucinations or delusions are more likely to have later suicidal thoughts or attempts, an international study has found.

30 Aug 2017

First-of-its-kind study compares long-term weight gain across different psychotic disorders

Obesity is a major public health problem in the United States, as an estimated 35 percent of Americans are obese and have a body mass index (BMI) of 30 or more.

23 Aug 2017

Climbing cost of decades-old drugs threatens to break Medicaid bank

Skyrocketing price tags for new drugs to treat rare diseases have stoked outrage nationwide. But hundreds of old, commonly used drugs cost the Medicaid program billions of extra dollars in 2016 vs. 2015, a Kaiser Health News data analysis shows.

14 Aug 2017

Screening individuals at-risk for psychosis may help predict future violent behavior

A new study of young persons at clinical high-risk of developing psychosis has identified measures of violence potential that may be useful in predicting both the increased risk of future violent behavior and the actual development of psychosis.

17 Jul 2017

University of Warwick receives multi-million pound grant to improve healthcare in slums

The University of Warwick is to receive more than £5 million to find better ways of delivering healthcare to some of the world's poorest people.

14 Jul 2017

University of Warwick researchers receive £1.5 million grant to tackle psychosis in India

University of Warwick researchers are to improve the lives of India's millions of psychosis sufferers.

14 Jul 2017

Psychosis News and Research

Further Reading

FDA approves first digital pill with sensor - Abilify MyCite

FDA approves first drug with digital ingestion tracking system

ACADIA Pharmaceuticals announces results from Phase II study of antipsychotic in Alzheimer's disease psychosis

Healthy people with psychotic-like experiences have altered brain dynamics, study finds

Cochrane review provides clarity about safety of mefloquine for preventing malaria in travelers

Sunovion announces results from Phase 3 clinical study of new drug in children, adolescents with bipolar depression

Study explores mechanisms of psychotherapy in individuals at very high risk of psychosis

USC study reveals how schizophrenia has biological effect on the entire brain

Expert report provides new insight into nature of mental illness

Web-based therapies increase likelihood of people with severe mental illness finding work

Study finds brain chemical elevations in young people experiencing first episode of psychosis

Researchers find gaps in knowledge about causes of symptoms in dementia patients

Study reveals marijuana's potential effects in individuals at high risk for psychotic disorder

New approaches to prevent or treat antipsychotic-induced supersensitivity psychosis

Psychotic experiences double risk of suicidal thoughts and behaviors, study finds

First-of-its-kind study compares long-term weight gain across different psychotic disorders

Climbing cost of decades-old drugs threatens to break Medicaid bank

Screening individuals at-risk for psychosis may help predict future violent behavior

University of Warwick receives multi-million pound grant to improve healthcare in slums

University of Warwick researchers receive £1.5 million grant to tackle psychosis in India

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News